quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:21:16·232d
SECFiling
ImmunoPrecise Antibodies Ltd. logo

SEC Form 6-K filed by ImmunoPrecise Antibodies Ltd.

IPA· ImmunoPrecise Antibodies Ltd.
Health Care
Original source

Companies

  • IPA
    ImmunoPrecise Antibodies Ltd.
    Health Care

Recent analyst ratings

  • Dec 2UpdateH.C. Wainwright$9.00
  • Oct 25UpdateBenchmark$12.00
  • Oct 25UpdateThe Benchmark Company$12.00

Related

  • PR232d
    ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to "HYFT"
  • SEC233d
    SEC Form 6-K filed by ImmunoPrecise Antibodies Ltd.
  • PR233d
    ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
  • SEC239d
    SEC Form 6-K filed by ImmunoPrecise Antibodies Ltd.
  • PR239d
    ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation
  • SEC260d
    SEC Form 6-K filed by ImmunoPrecise Antibodies Ltd.
  • PR260d
    ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation
  • PR260d
    AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022